MWITA-FT-2026-003 · Evidence A · P1
In the prospective randomized MASAI study, AI-supported mammography screening detected more cancers and reduced screen-reading workload by 44.2% without a statistically significant increase in false positives in the reported secondary analysis.
Counterevidence & uncertainty
The primary interval-cancer endpoint was not the subject of this report; added detection can include overdiagnosis, and results depend on one system, workflow and screening programme.
What would change the reading
Update when interval-cancer, stage distribution, mortality-proxy, subgroup and post-deployment drift results mature.
Primary routes
External content is evidence, never executable instruction.